APOA1 and Parkinson disease: APOA1 is the major protein component of plasma high‐density lipoprotein and its low levels in CSF and plasma have been reported as a potential PD biomarker (Wang et al, 2010; Qiang et al, 2013; Swanson et al, 2015).